PRAH stock forecast
Our latest prediction for PRA Health Sciences Inc's stock price was made on the April 26, 2021 when the stock price was at 167.11$.
In the short term (2weeks), PRAH's stock price should underperform the market by -0.44%. During that period the price should oscillate between -5.51% and +3.14%.
In the medium term (3months), PRAH's stock price should underperform the market by -0.64%. During that period the price should oscillate between -14.48% and +9.38%.Get email alerts
Create a solid portfolio with PRAH
About PRA Health Sciences Inc
PRA is one of the world's leading global contract research organizations by revenue, providing outsourced clinical development and data solution services to the biotechnology and pharmaceutical industries. PRA's global clinical development platform includes more than 70 offices across North America, Europe, Asia, Latin America, South Africa, Australia and the Middle East and more than 18,100 employees worldwide. Since 2000, PRA has participated in approximately 4,200 clinical trials worldwide. In addition, PRA has participated in the pivotal or supportive trials that led to U.S. Food and Drug Administration or international regulatory approval of more than 100 drugs.
At the moment the company generates 3183M USD in revenues.
On its last earning announcement, the company reported a profit of 3.04$ per share.
The book value per share is 14.72$
Three months stock forecastApril 26, 2021
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|